Valuation (17%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.25 | 48.32 |
PEG Ratio (TTM) | -0.34 | 0.31 |
P/S Ratio (TTM) | 1.69 | 3.59 |
P/B Ratio (TTM) | 1.61 | 2.46 |
P/FCF Ratio (TTM) | -2.80 | 35.62 |
Price to 5YR AVG Earnings Ratio | N/A | 51.60 |
Price to 5YR AVG FCF Ratio | N/A | 29.61 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -41.37% | 1.32% |
ROE (TTM) | -89.50% | -3.04% |
Net Profit Margin (TTM) | -72.16% | -1.57% |
ROIC 5YR AVG | N/A | 137.75% |
Growth (28%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 0.96% | -43.62% | N/A |
Revenue | 22.12% | 20.94% | N/A |
Net Income | 0.73% | -46.89% | N/A |
Cash Flow | 5.32% | -47.02% | N/A |
Health (35%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.57 | 2.90 |
Quick Ratio (TTM) | 1.41 | 2.87 |
D/E Ratio (TTM) | 0.11 | 1.33 |
Interest Coverage (TTM) | N/A | -0.49 |
Piotroski F-Score | 5 | 5 |
Altman Z-Score | N/A | 4.04 |
LTL to 5YR AVG FCF | N/A | 51.70 |
Shares Outstanding Growth 5YR AVG | N/A | 66.37% |